Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Chubb
McKesson
Fish and Richardson
Fuji
Queensland Health
Colorcon
Healthtrust
Daiichi Sankyo

Generated: October 19, 2017

DrugPatentWatch Database Preview

LOPROX Drug Profile

« Back to Dashboard

Which patents cover Loprox, and what generic Loprox alternatives are available?

Loprox is a drug marketed by Medimetriks Pharms and Medicis and is included in three NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has forty-three patent family members in thirty-three countries.

The generic ingredient in LOPROX is ciclopirox. There are ten drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.

Summary for Tradename: LOPROX

US Patents:2
Applicants:2
NDAs:3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list54
Patent Applications: see list3,031
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LOPROX at DailyMed

Pharmacology for Tradename: LOPROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medimetriks Pharms
LOPROX
ciclopirox
SUSPENSION;TOPICAL019824-001Dec 30, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003ATRXYesYes► Subscribe► Subscribe ► Subscribe
Medimetriks Pharms
LOPROX
ciclopirox
CREAM;TOPICAL018748-001Dec 30, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003ATRXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LOPROX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medimetriks Pharms
LOPROX
ciclopirox
SUSPENSION;TOPICAL019824-001Dec 30, 1988► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003► Subscribe► Subscribe
Medimetriks Pharms
LOPROX
ciclopirox
CREAM;TOPICAL018748-001Dec 30, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for LOPROX

Drugname Dosage Strength RLD Submissiondate
ciclopiroxGel0.77%Loprox5/10/2006

International Patent Family for Tradename: LOPROX

Country Document Number Estimated Expiration
Israel129141► Subscribe
Germany19639818► Subscribe
Japan2006176540► Subscribe
Spain2167721► Subscribe
Slovenia928183► Subscribe
South Africa9708640► Subscribe
African Intellectual Property Organization (OAPI)11028► Subscribe
Brazil9711575► Subscribe
Germany59705697► Subscribe
Australia4774697► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
UBS
US Department of Justice
Colorcon
Boehringer Ingelheim
Cantor Fitzgerald
Teva
Cerilliant
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot